Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BABA vs GSK✓SelectedUSD · GSKBABA vs GSK performance historyLatest closeAs of+0.02%11/13
Stock and ETF performance explorer

BABA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+11.7%
GSK return
+105.0%
Excess return
-93.2%
Maximum drawdown
-80.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D0.0%+0.5%-0.5%-0.1%
7D-13.8%+1.1%-14.9%-14.1%
30D-15.1%+6.3%-21.4%-16.7%
3M-22.7%+1.8%-24.6%-23.4%
6M-34.7%+1.7%-36.3%-35.5%
YTD-35.0%+6.5%-41.6%-37.1%
1Y-40.4%+9.5%-49.9%-42.9%
3Y+21.9%+65.3%-43.4%-1.5%
5Y-39.9%+43.7%-83.6%-49.4%
All+11.7%+105.0%-93.2%-20.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling